Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial

Matthew H. Kulke, D. Hoersch,Martyn Caplin,Lowell Anthony,Emily K. Bergsland,Kjell Öberg,Staffan Welin,Richard R.P. Warner,Catherine Lombard-Bohas,Pamela L. Kunz,Enrique Grande,Juan W. Valle,Douglas Fleming,Pablo Lapuerta,Phillip Banks,Shanna Jackson,Darren Wheeler,Brian Zambrowicz,Arthur T. Sands,Marianne Pavel

Pancreas（2016）

引用 0|浏览1

暂无评分

摘要

Telotristat Etiprate Shows Benefit in Treating Patients With Carcinoid Syndrome That is Inadequately Controlled by Somatostatin Analog Therapy in the Phase 3 TELESTAR Clinical Trial

查看译文

关键词

somatostatin analog therapy,carcinoid syndrome,telestar

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要